Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 5CNS 5Other hematologic neoplasm 4Lymphoid 3Sarcoma 1Other neoplasm 1Other 1Myeloid 1Gastrointestinal 1Dermatologic 1

Conditions

Precancerous Conditions 32Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Lymphoma, Non-Hodgkin 12Lymphoma, Mantle-Cell 12Lymphoma, Large-Cell, Immunoblastic 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Follicular 12Leukemia, Lymphocytic, Chronic, B-Cell 12Leukemia 12Burkitt Lymphoma 12Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11Neoplasms, Plasma Cell 11Multiple Myeloma 11Monoclonal Gammopathy of Undetermined Significance 11Lymphoma, B-Cell, Marginal Zone 11Leukemia, Large Granular Lymphocytic 11Leukemia, Hairy Cell 11Immunoglobulin Light-chain Amyloidosis 11Waldenstrom Macroglobulinemia 10Thrombocythemia, Essential 10Primary Myelofibrosis 10Myeloproliferative Disorders 10Myelodysplastic Syndromes 10Leukemia, Myeloid, Acute 10Immunoblastic Lymphadenopathy 10Hodgkin Disease 10Polycythemia Vera 9Lymphoma, Large-Cell, Anaplastic 9Leukemia, Prolymphocytic 9

Interventions

sargramostim 1Cyclophosphamide 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Drug-Related Side Effects and Adverse Reactions × Other neoplasm × Clear all
NCT00004036 2013-12-19

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
30 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Leukemia, Large Granular Lymphocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Primary Myelofibrosis, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡